Lang Bu

567 total citations
19 papers, 378 citations indexed

About

Lang Bu is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Lang Bu has authored 19 papers receiving a total of 378 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Immunology and 6 papers in Oncology. Recurrent topics in Lang Bu's work include interferon and immune responses (6 papers), Ubiquitin and proteasome pathways (3 papers) and Cancer-related molecular mechanisms research (3 papers). Lang Bu is often cited by papers focused on interferon and immune responses (6 papers), Ubiquitin and proteasome pathways (3 papers) and Cancer-related molecular mechanisms research (3 papers). Lang Bu collaborates with scholars based in China, United States and Canada. Lang Bu's co-authors include Jianping Guo, Qiwei Jiang, Deyin Guo, Bing Gao, Qing Guan, Wei Xie, Ying Lin, Zhen Qu, Xueji Wu and Chunhui Yuan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Molecular Cell.

In The Last Decade

Lang Bu

18 papers receiving 374 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lang Bu China 12 208 97 96 78 40 19 378
Huijun Zhu China 12 286 1.4× 115 1.2× 109 1.1× 69 0.9× 40 1.0× 32 501
Jacob Cardenas United States 10 201 1.0× 143 1.5× 76 0.8× 79 1.0× 26 0.7× 15 468
José Manuel Lerma-Díaz Mexico 13 227 1.1× 106 1.1× 98 1.0× 70 0.9× 28 0.7× 17 423
Archana Varadaraj United States 11 257 1.2× 59 0.6× 58 0.6× 54 0.7× 24 0.6× 17 512
Shishi Tao China 7 241 1.2× 70 0.7× 75 0.8× 64 0.8× 40 1.0× 12 392
Valesca Anschau Brazil 7 155 0.7× 77 0.8× 48 0.5× 49 0.6× 39 1.0× 12 292
Yuanzheng Yang United States 12 167 0.8× 110 1.1× 46 0.5× 60 0.8× 56 1.4× 24 402

Countries citing papers authored by Lang Bu

Since Specialization
Citations

This map shows the geographic impact of Lang Bu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lang Bu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lang Bu more than expected).

Fields of papers citing papers by Lang Bu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lang Bu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lang Bu. The network helps show where Lang Bu may publish in the future.

Co-authorship network of co-authors of Lang Bu

This figure shows the co-authorship network connecting the top 25 collaborators of Lang Bu. A scholar is included among the top collaborators of Lang Bu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lang Bu. Lang Bu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Song, Peipei, Qiwei Jiang, Xiaobo Wu, et al.. (2025). Palmitic acid and palmitoylation in cancer: Understanding, insights, and challenges. The Innovation. 6(8). 100918–100918.
2.
Yang, Zixiao, Liaoxun Lu, Zibo Li, et al.. (2025). RNF167 mediates atypical ubiquitylation and degradation of RLRs via two distinct proteolytic pathways. Nature Communications. 16(1). 1920–1920. 3 indexed citations
3.
Jiang, Qiwei, Lang Bu, & Jianping Guo. (2025). Insights into palmitoylation-mediated regulation of inflammasomes. Trends in Immunology. 46(4). 266–269. 4 indexed citations
4.
Gao, Bing, Xueji Wu, Lang Bu, et al.. (2024). Atypical inflammatory kinase IKBKE phosphorylates and inactivates FoxA1 to promote liver tumorigenesis. Science Advances. 10(6). eadk2285–eadk2285. 9 indexed citations
5.
Bu, Lang, Huan Wang, Shuishen Zhang, et al.. (2024). Targeting APT2 improves MAVS palmitoylation and antiviral innate immunity. Molecular Cell. 84(18). 3513–3529.e5. 18 indexed citations
6.
Zhang, Xiaomei, Qiwei Jiang, Yaqing Su, et al.. (2023). AMPK phosphorylates and stabilises copper transporter 1 to synergise metformin and copper chelator for breast cancer therapy. British Journal of Cancer. 128(8). 1452–1465. 21 indexed citations
7.
Sun, Zicheng, Qiwei Jiang, Bing Gao, et al.. (2023). AKT Blocks SIK1-Mediated Repression of STAT3 to Promote Breast Tumorigenesis. Cancer Research. 83(8). 1264–1279. 25 indexed citations
8.
Hou, Panpan, Xiao-Dong Li, Haipeng Zhang, et al.. (2022). CDK4/6 Inhibition Enhances Oncolytic Virus Efficacy by Potentiating Tumor-Selective Cell Killing and T-cell Activation in Refractory Glioblastoma. Cancer Research. 82(18). 3359–3374. 21 indexed citations
9.
Li, Ping, Junyu Wu, Shujie Liu, et al.. (2022). The RNA polymerase of cytoplasmically replicating Zika virus binds with chromatin DNA in nuclei and regulates host gene transcription. Proceedings of the National Academy of Sciences. 119(49). e2205013119–e2205013119. 10 indexed citations
10.
Xie, Wei, Qiwei Jiang, Xueji Wu, et al.. (2022). IKBKE phosphorylates and stabilizes Snail to promote breast cancer invasion and metastasis. Cell Death and Differentiation. 29(8). 1528–1540. 24 indexed citations
11.
Zhang, Zhengkun, Lang Bu, Junhang Luo, & Jianping Guo. (2022). Targeting protein kinases benefits cancer immunotherapy. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1877(4). 188738–188738. 7 indexed citations
12.
Jiang, Qiwei, Nana Zheng, Lang Bu, et al.. (2021). SPOP-mediated ubiquitination and degradation of PDK1 suppresses AKT kinase activity and oncogenic functions. Molecular Cancer. 20(1). 100–100. 57 indexed citations
13.
Wu, Junyu, Chunyan Wu, Fan Xing, et al.. (2021). Endogenous reverse transcriptase and RNase H-mediated antiviral mechanism in embryonic stem cells. Cell Research. 31(9). 998–1010. 13 indexed citations
14.
Bu, Lang, Huan Wang, Panpan Hou, et al.. (2020). The Ubiquitin E3 Ligase Parkin Inhibits Innate Antiviral Immunity Through K48-Linked Polyubiquitination of RIG-I and MDA5. Frontiers in Immunology. 11. 1926–1926. 24 indexed citations
15.
Wang, Huan, Lang Bu, Chao Wang, et al.. (2018). The Hsp70 inhibitor 2-phenylethynesulfonamide inhibits replication and carcinogenicity of Epstein–Barr virus by inhibiting the molecular chaperone function of Hsp70. Cell Death and Disease. 9(7). 734–734. 17 indexed citations
16.
Cao, Yuanyuan, Hongyun Wang, Yang Liu, et al.. (2017). PTEN-L promotes type I interferon responses and antiviral immunity. Cellular and Molecular Immunology. 15(1). 48–57. 20 indexed citations
17.
Rong, Yuan, Chunhui Yuan, Zhen Qu, et al.. (2016). Doxorubicin resistant cancer cells activate myeloid-derived suppressor cells by releasing PGE2. Scientific Reports. 6(1). 23824–23824. 64 indexed citations
18.
Wang, Ying, Pengchao Hu, Fangfang Gao, et al.. (2014). Ritonavir-Induced Hepatotoxicity and Ultrastructural Changes of Hepatocytes. Ultrastructural Pathology. 38(5). 329–334. 10 indexed citations
19.
Liu, Jian, Jingfang Zhang, Jinzhi Lu, et al.. (2012). Astragalus polysaccharide stimulates glucose uptake in L6 myotubes through AMPK activation and AS160/TBC1D4 phosphorylation. Acta Pharmacologica Sinica. 34(1). 137–145. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026